Product image of Metformina Tolife (Metformin Hydrochloride) supplied by GNH India

Metformina Tolife

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformina Tolife (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformina Tolife, is a Biguanide presented as an oral tablet for oral administration. It lowers elevated blood glucose by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity, and is indicated for adults with type 2 diabetes mellitus.

GNH India supplies Metformina Tolife as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled manufacturing and reliable global distribution. The product complies with EU regulatory standards and is available for bulk procurement.

Manufacturer / TM Owner

Towa Pharmaceutical S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformina Tolife (metformin hydrochloride) is used in the management of disorders related to impaired glucose metabolism.

  • Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.
  • Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes when combined with lifestyle measures.
  • Polycystic ovary syndrome: reduces insulin resistance and may improve menstrual regularity and ovulation.

How It Works

  • Metformin hydrochloride acts primarily by activating AMP‑activated protein kinase (AMPK), which suppresses hepatic gluconeogenesis and reduces liver glucose output. It also increases insulin‑mediated glucose uptake in skeletal muscle and adipose tissue and modestly decreases intestinal glucose absorption, leading to lower plasma glucose concentrations without directly stimulating insulin secretion.

Side Effects

Metformina Tolife may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite.
  • Diarrhea: frequent loose stools, especially early in therapy.
  • Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects

  • Lactic acidosis: a rare but potentially fatal accumulation of lactate.
  • Vitamin B12 deficiency: may develop with long‑term use.
  • Severe hypoglycemia: when combined with insulin or sulfonylureas.

Precautions & Warnings

When prescribing Metformina Tolife, clinicians should observe several safety considerations.

  • Renal function: assess creatinine clearance before initiation and periodically thereafter.
  • Hepatic status: avoid use in patients with significant liver disease.
  • Risk of lactic acidosis: discontinue if patient develops hypoxia, sepsis, or acute heart failure.
  • Concomitant medications: review for drugs that may impair renal clearance or increase metformin levels.
  • Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation.
  • Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Avoid Interactions

Metformina Tolife can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Iodinated contrast media: may precipitate lactic acidosis; withhold metformin before and after the procedure.
  • Cimetidine: can increase metformin plasma concentrations.
  • Renal‑impairing diuretics (e.g., furosemide): heighten risk of accumulation and lactic acidosis.

Moderate Interactions (Monitor Closely)

  • Sulfonylureas or insulin: increased risk of hypoglycemia; dose adjustments may be required.
  • Beta‑blockers: may mask hypoglycemia symptoms.
  • ACE inhibitors or ARBs: monitor renal function and electrolytes.
  • Corticosteroids: may raise blood glucose, necessitating closer glycemic monitoring.

Frequently Asked Questions

Metformina Tolife contains metformin hydrochloride and is used to improve blood glucose control in adults with type 2 diabetes mellitus. It may also be prescribed for prediabetes and polycystic ovary syndrome to address insulin resistance.

Metformin works by activating AMP‑activated protein kinase, which suppresses glucose production in the liver and enhances insulin‑mediated glucose uptake in muscle and fat tissues. It also modestly reduces intestinal glucose absorption, helping lower overall blood sugar levels.

The appropriate dose of Metformina Tolife is determined by the prescribing healthcare professional based on the individual’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Metformina Tolife should be used during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant. The decision must be made by a qualified healthcare provider after evaluating the specific clinical situation.

To order Metformina Tolife, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformina Tolife (metformin) is a first‑line oral agent for type 2 diabetes, distinguished by its ability to lower glucose without causing hypoglycemia when used alone. Compared with sulfonylureas or insulin, it has a lower risk of weight gain and hypoglycemia, but may cause gastrointestinal side effects.

Metformina Tolife should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Metformina Tolife is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets are swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare professional.

The most serious risks include lactic acidosis, a rare but potentially fatal condition, and severe hypoglycemia when combined with insulin or sulfonylureas. Long‑term therapy may also lead to vitamin B12 deficiency, so periodic monitoring is recommended.

Metformina Tolife is contraindicated in patients with severe renal impairment, acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with known hypersensitivity to metformin. Caution is also advised for individuals with significant liver disease or conditions predisposing to hypoxia.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT